Neue Suche | Kongressdetail
mail
Druckansicht
 
 

1st Rare and Genetic Neurodegenerative Drug Development Summit

Evvnt Promotion / evvnt
-
22.06.2022 - 23.06.2022  Online
Time: 08:50 - 16:00
 
Kongressthemen
Advance Life-Changing Therapies for Adolescents and Adults With Rare Neurological Disorders

Welcome to the 1st Rare and Genetic Neurodegenerative Drug Development Summit! This trailblazing meeting will be discussing, debating and exploring pivotal rare and genetic neurodegenerative disease research making industry news headlines.

Pioneers in this exclusive industry are convening online, this June, to network and learn from experts in pharma, biotech and academia.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Speakers: Anka G. Ehrhardt, Director, Cell-Based Assays / Analytical Research and Development, Merck, Christopher Missling, President and Chief, Executive Officer, Anavex Life Sciences, David Theron, Development Director in Neurology, Servier & more
 

Anfragen und Anmeldung:

https://go.evvnt.com/1056250-2?pid=4832
Herr Hanson Wade
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
Drug Developer Pricing - Conference Pass: USD 2099.0, Solution Provider Pricing - Conference Pass: USD 2599.0
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Swiss Tropical and Public Health InstituteÖsterreichisches Rotes KreuzCenter of ExcellenceCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioHelix - Forschung & Beratung WienÖsterreichische Gesellschaft für Public HealthCharité International AcademyAlumni Club Medizinische Universität Wien